Related Experiment Video

Updated: Apr 14, 2026

Assaying the Kinase Activity of LRRK2 in vitro
06:09

Assaying the Kinase Activity of LRRK2 in vitro

Published on: January 18, 2012

23.1K

Cellular processes associated with LRRK2 function and dysfunction

Rebecca Wallings1, Claudia Manzoni2,3, Rina Bandopadhyay1

  • 1Reta Lila Weston Institute of Neurological Studies and Department of Molecular Neuroscience, UCL Institute of Neurology, London, UK.

The FEBS Journal
|April 23, 2015
PubMed

Insights

Mutations in the leucine-rich repeat kinase 2 (LRRK2) gene are key to Parkinson's disease. Understanding LRRK2's function and regulation is crucial for both familial and sporadic forms of this neurodegenerative disorder.

Area of Science:

  • Neuroscience
  • Genetics
  • Cell Biology

Background:

  • Mutations in the leucine-rich repeat kinase 2 (LRRK2) gene are the most common cause of monogenic Parkinson's disease.
  • LRRK2's role in sporadic Parkinson's disease is increasingly recognized, with similar pathological phenotypes observed.
  • LRRK2 is a large protein possessing both GTPase and kinase functions, with disease-associated mutations located in its enzymatic core.

Purpose of the Study:

  • To review the current understanding of LRRK2's physiological and neurotoxic properties.
  • To explore LRRK2's diverse cellular functions and signaling pathways.
  • To discuss potential phosphorylation substrates, functional partners, and signaling mechanisms.

Main Methods:

  • Literature review of LRRK2 research.
  • Analysis of LRRK2's association with cellular functions (mitochondrial function, vesicle trafficking, autophagy).
  • Discussion of LRRK2's role in health and disease, including immune cell involvement and oxidative stress regulation.

Main Results:

  • LRRK2 is implicated in various cellular processes, including mitochondrial function, endocytosis, and autophagy.
  • Modulation of LRRK2 activity significantly impacts Parkinson's disease onset and progression.
  • Oxidative stress is identified as a key regulator of LRRK2 activity and cellular function.

Conclusions:

  • Further research into LRRK2's physiological roles and pathological mechanisms is essential.
  • Understanding LRRK2 signaling is critical for developing therapeutic strategies for Parkinson's disease.
  • The review highlights the multifaceted role of LRRK2 in both health and disease, emphasizing its potential as a therapeutic target.
Keywords:
GTPaseLRRK2LRRK2 kinase inhibitonautophagycytoskeletongeneticskinaseretromer complexsignalling mechanismsvesicle trafficking

More Related Videos

Metabolic Labeling of Leucine Rich Repeat Kinases 1 and 2 with Radioactive Phosphate11:31

Metabolic Labeling of Leucine Rich Repeat Kinases 1 and 2 with Radioactive Phosphate

Published on: September 18, 2013

10.6K
Rab10 Phosphorylation Detection by LRRK2 Activity Using SDS-PAGE with a Phosphate-binding Tag08:55

Rab10 Phosphorylation Detection by LRRK2 Activity Using SDS-PAGE with a Phosphate-binding Tag

Published on: December 14, 2017

16.3K

Related Concept Videos

Lysosomal Hydrolases01:22

Lysosomal Hydrolases

Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
4.8K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
6.5K
Neural Regulation01:37

Neural Regulation

Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
45.1K
Post-translational Translocation of Proteins to the RER01:27

Post-translational Translocation of Proteins to the RER

A sizable fraction of proteins destined for ER are first synthesized in the cell cytosol and then transported across the ER membrane–a process called post-translational translocation. Similar to cotranslationally translocated proteins, these proteins also use the Sec translocon complex to enter the ER lumen.
Targeting proteins to the ER
Hsp40 and Hsp70 chaperone molecules bind the translated proteins in the cytosol to prevent their folding. The chaperone binding helps to keep the signal...
8.2K
Regulated Protein Degradation02:58

Regulated Protein Degradation

It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
9.3K
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
19.7K